Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer
Authors
Keywords
Ruthenium, Organometallic, Dendron, Carbosilane, Schiff base, Ex vivo, Prostate cancer
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 207, Issue -, Pages 112695
Publisher
Elsevier BV
Online
2020-08-18
DOI
10.1016/j.ejmech.2020.112695
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models
- (2020) Rashed M. Almuqbil et al. MOLECULAR PHARMACEUTICS
- Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer
- (2020) Natalia Sanz del Olmo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vitro and in vivo evaluation of first-generation carbosilane arene Ru(II)-metallodendrimers in advanced prostate cancer
- (2019) Marta Maroto-Diaz et al. EUROPEAN POLYMER JOURNAL
- Anticancer Activity of Dendriplexes against Advanced Prostate Cancer from Protumoral Peptides and Cationic Carbosilane Dendrimers
- (2019) María Sánchez-Milla et al. BIOMACROMOLECULES
- In Vitro Anticancer Properties of Copper Metallodendrimers
- (2019) Hołota et al. Biomolecules
- Metal‐based phosphorus dendrimers as novel nanotherapeutic strategies to tackle cancers: A concise overview
- (2019) Liang Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug
- (2019) Sylwia Michlewska et al. Biomolecules
- Synthesis of bow-tie carbosilane dendrimers and their HIV antiviral capacity: A comparison of the dendritic topology on the biological process
- (2019) Carlos E. Gutierrez-Ulloa et al. EUROPEAN POLYMER JOURNAL
- Synthesis and structural characterization of carbosilane ruthenium(II) metallodendrons containing cymene units
- (2019) Marta Maroto-Diaz et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications
- (2019) Ana Santos et al. Materials
- New bow-tie cationic carbosilane dendritic system with a curcumin core as an anti-breast cancer agent
- (2018) Tania Lozano-Cruz et al. NEW JOURNAL OF CHEMISTRY
- Sulfonate-ended carbosilane dendrimers with a flexible scaffold cause inactivation of HIV-1 virions and gp120 shedding
- (2018) Daniel Sepúlveda-Crespo et al. Nanoscale
- Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes
- (2016) Marta Maroto-Díaz et al. DALTON TRANSACTIONS
- Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer
- (2016) James P. Parker et al. Metallomics
- Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
- (2016) Hitesh Kulhari et al. Scientific Reports
- Selenium–Platinum Coordination Dendrimers with Controlled Anti-Cancer Activity
- (2015) Tianyu Li et al. ACS Applied Materials & Interfaces
- Synthesis, characterization and antibacterial behavior of water-soluble carbosilane dendrons containing ferrocene at the focal point
- (2015) Tania Lozano-Cruz et al. DALTON TRANSACTIONS
- Bifunctional Chelating Agents Based on Ionic Carbosilane Dendrons with DO3A at the Focal Point and Their Complexation Behavior with Copper(II)
- (2015) Silvia Moreno et al. INORGANIC CHEMISTRY
- Type I Collagen Receptor (α2β1) Signaling Promotes Prostate Cancer Invasion through RhoC GTPase
- (2015) Christopher L. Hall et al. NEOPLASIA
- Anti-proliferative Activity of Nano-Formulated Phenolato Titanium(IV) Complexes Against Cancer Cells
- (2014) Sigalit Meker et al. ChemMedChem
- In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
- (2014) Andrea Weiss et al. Chemical Science
- Monometallic nickel(II) complexes containing N,N′-iminopyridine chelating ligands with dendritic substituents: The influence of dendrimer topology on the catalytic oligomerization and polymerization of ethylene
- (2013) Francisco Martínez-Olid et al. INORGANICA CHIMICA ACTA
- New water-soluble ruthenium(II) cytotoxic complex: Biological activity and cellular distribution
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Ferrocene incorporated PAMAM dendrons: synthesis, characterization, and anti-cancer activity against AGS cell line
- (2013) Tuğba Sağır et al. MEDICINAL CHEMISTRY RESEARCH
- From Metallodrugs to Metallodendrimers for Nanotherapy in Oncology: A Concise Overview
- (2012) S. El Kazzouli et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis of palladium(II) complexes of bidentate phosphano ligands with carbosilane substituents
- (2012) Susana Vigo et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Therapeutic applications of gold complexes: lipophilic gold(iii) cations and gold(i) complexes for anti-cancer treatment
- (2011) Chi-Ming Che et al. CHEMICAL COMMUNICATIONS
- Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands
- (2009) M. Helena Garcia et al. JOURNAL OF INORGANIC BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started